Mutations in C9orf72, TDP-43, FUS, and VCP have been found to be closely associated with FTD/ALS and represent promising biomarker candidates; however, there is still an absence of protein biomarkers for early disease detection. This evidence concerns the gene TARDBP and amyotrophic lateral sclerosis.